GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Mosaic Immunoengineering CPMV · USD

Information Technology · US listing · 🇺🇸 United States

Compare

0.06

-24.05%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$687,846

FY2015FY2025

Free cash flow

−$111,397

FY2015FY2025

Shareholders' equity

−$7.5m

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016FY2015
Research and development$63,981$183,867$435,449$1.0m$1.5m—————
Operating income−$616,119−$879,655−$1.4m−$2.6m−$3.5m−$996,019−$734,062−$1.0m−$1.2m−$1.6m
Net income−$687,846−$921,983−$1.0m−$2.4m−$3.7m−$1.1m−$798,463−$1.2m−$45,368−$1.3m
Diluted earnings per share-0.09-0.13-0.14-0.33-0.51-1.32-0.99-1.51-0.06-1.59

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016FY2015
Total assets$19,882$141,611$179,533$261,277$269,494$818,618$1.9m$2.6m$3.8m$3.8m
Cash and short-term investments—————————$3.1m
Total liabilities$7.5m$6.9m$6.1m$5.1m$3.1m$182,595$228,212$84,839$56,587$73,500
Debt$1.5m$1.4m$1.3m$1.2m$735,148—————
Shareholders' equity−$7.5m−$6.8m−$5.9m−$4.9m−$2.8m$636,023$1.7m$2.5m$3.7m$3.7m
Shares outstanding7m7m7m7m7m1m1m1m1m—

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016FY2015
Cash from operations−$111,397−$241,159−$497,467−$690,129−$679,236$3,000−$760,766−$880,286−$1.3m−$1.6m
Capital spending———————−$1,465−$2,703—
Free cash flow−$111,397−$241,159−$497,467−$690,129−$679,236$3,000−$760,766−$881,751−$1.3m−$1.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−$156,721−$154,802−$148,133−$144,358−$148,854−$174,774−$150,157−$186,430
Net income−$177,496−$175,351−$169,137−$165,361−$172,028−$181,320−$153,044−$186,730
Diluted earnings per share-0.02-0.02-0.02-0.02-0.02-0.03-0.02-0.03
Total assets$3,278$9,828$19,882$55,298$57,699$97,784$141,611$39,950
Debt$1.5m$1.5m$1.5m$1.4m$1.4m$1.4m$1.4m$1.4m
Shareholders' equity−$7.8m−$7.7m−$7.5m−$7.3m−$7.1m−$7.0m−$6.8m−$6.6m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-38.3%—-9.0%
Net income-33.9%—-5.9%

Valuation history

At each fiscal year end

FY2025
Price to earnings-0.1

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return1903%1149%-47%8843%2%198300%224%50%167%-47%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 2 Mar 2007.

  • 500-to-1 reverse split · 2 Dec 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.